SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-093195 from Damon Inc. (DMNIF)

Damon Inc.
Date: Nov. 1, 2024 · CIK: 0002000640 · Accession: 0001213900-24-093195

Regulatory Compliance Financial Reporting Business Model Clarity

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-282359

Referenced dates: October 24, 2024

Date
October 31, 2024
Author
Kevin Friedmann
Form
CORRESP
Company
Damon Inc.

Letter

VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Division of Corporation Finance Office of Technology Attention: Claire DeLabar, Staff Attorney Re: Grafiti Holding Inc. Registration Statement on Form S-1 Filed September 27, 2024 File No. 333-282359

Dear Mses. DeLabar and Woo and Messrs. Pattan and Crispino:

On behalf of Grafiti Holding Inc. (the “Company”), we are submitting via EDGAR for review by the staff of the Securities and Exchange Commission (the “Staff”) this response letter and the accompanying Amendment No. 1 (“Amendment No. 1”) to the Company’s Registration Statement on Form S-1 initially filed via EDGAR on September 27, 2024 (the “Registration Statement”). This letter and Amendment No. 1 reflect the Company’s acknowledgement and response to the comments received from the Staff contained in the Staff’s letter dated October 24, 2024 (the “Comment Letter”). For your convenience, the Company is providing to the Staff a supplemental typeset copy of Amendment No. 1 marked to indicate the changes form the Registration Statement that was filed on September 27, 2024.

The Staff’s comments in the Comment Letter are reproduced in italics in this letter, and the corresponding responses of the Company are shown below each comment. All references to page numbers in the Company’s responses are to the page numbers in Amendment No. 1.

Registration Statement on Form S-1

Plan of Distribution, page 76

1. Please disclose whether your common stock has a history of trading in private transactions. If so, disclose the extent of the coordination between your Advisor and Nasdaq about the sales prices in recent private transactions, including high and low sales prices. To the extent material, add a risk factor to address the risk that the opening trading price may not be related to historical sales prices.

Response: The Company’s common shares have no history of trading in private transactions. The Company has updated its disclosure accordingly, as requested. Please see the additional disclosure on page 77.

Mses. DeLabar and Woo and Messrs. Pattan and Crispino

Securities and Exchange Commission

October 31, 2024

Page 2

2. Please disclose the process of the price validation test, including the methodology and process that Maxim will use to select price bands for purposes of applying the price validation test.

Response: The Company has disclosed in Amendment No. 1 the process of the price validation test, including the methodology and process that Maxim will use to select price bands for purposes of applying the price validation test, as requested. Please see the additional disclosure on page 77.

3. We note that Maxim Group will serve as the company’s financial advisor in connection with the direct offering on Nasdaq. Please tell us whether Maxim is considered independent under Nasdaq’s listing standards for direct listings. Please tell us whether Maxim provided any investing banking services to the company within the 12 months preceding the valuation or has engaged in investment banking services to the company in connection with the proposed listing, any related financings or other related transactions.

Response: The Company acknowledges the Staff’s comment and respectfully advises that Maxim is considered independent under Nasdaq’s listing standards for direct listings. Neither Maxim nor any affiliated entity has provided any investment banking services to the Company within the past 12 months or has engaged in investment banking services to the Company in connection with the proposed listing, any related financings or other related transactions.

Signatures, page II-6

4. We note that Nadir Ali has signed the registration statement on behalf of the registrant. Please revise the Signatures section to also include Mr. Ali's signature in his capacity as the registrant’s chief executive officer and director. Refer to the Instructions to Signatures in Form S-1.

Response: The Company acknowledges the Staff’s comment and has revised the Signatures section to also include Mr. Ali’s signature in his capacity as the registrant’s chief executive officer and director. Please see the revised Signatures section on page II-6.

* * *

We hope that the foregoing has been helpful to the Staff’s understanding of the Company’s disclosure and that the disclosure modifications in Amendment No. 1 are satisfactory to the Staff. If you have any questions or comments about this letter or need any further information, please call the undersigned at (312) 964-7763.

Very Truly
Yours
By:
/s/
Kevin Friedmann

Show Raw Text
CORRESP
1
filename1.htm

    Norton Rose Fulbright US
    LLP

    1045 W. Fulton Market, Suite
    1200

    Chicago, IL 60607 United
    States

    Direct line +1 (312) 964-7763

    kevin.friedmann@nortonrosefulbright.com

October 31, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Division of Corporation Finance

Office of Technology

    Attention:
    Claire DeLabar, Staff Attorney

    Robert Littlepage, Staff Attorney

    Matthew Crispino, Staff Attorney

    Jan Woo, Staff Attorney

    Re:
    Grafiti Holding Inc.

    Registration Statement on Form S-1

    Filed September 27, 2024

    File No. 333-282359

Dear Mses. DeLabar and Woo and Messrs. Pattan
and Crispino:

On behalf of Grafiti Holding
Inc. (the “Company”), we are submitting via EDGAR for review by the staff of the Securities and Exchange Commission (the
“Staff”) this response letter and the accompanying Amendment No. 1 (“Amendment No. 1”) to the Company’s
Registration Statement on Form S-1 initially filed via EDGAR on September 27, 2024 (the “Registration Statement”). This letter
and Amendment No. 1 reflect the Company’s acknowledgement and response to the comments received from the Staff contained in the
Staff’s letter dated October 24, 2024 (the “Comment Letter”). For your convenience, the Company is providing to the
Staff a supplemental typeset copy of Amendment No. 1 marked to indicate the changes form the Registration Statement that was filed on
September 27, 2024.

The Staff’s comments
in the Comment Letter are reproduced in italics in this letter, and the corresponding responses of the Company are shown below each comment.
All references to page numbers in the Company’s responses are to the page numbers in Amendment No. 1.

Registration Statement on Form S-1

Plan of Distribution, page 76

    1.
    Please disclose whether
    your common stock has a history of trading in private transactions. If so, disclose the extent of the coordination between your Advisor
    and Nasdaq about the sales prices in recent private transactions, including high and low sales prices. To the extent material, add
    a risk factor to address the risk that the opening trading price may not be related to historical sales prices.

Response: The Company’s common shares
have no history of trading in private transactions. The Company has updated its disclosure accordingly, as requested. Please see the
additional disclosure on page 77.

Mses. DeLabar and Woo and Messrs. Pattan and Crispino

Securities and Exchange Commission

October 31, 2024

Page 2

    2.
    Please disclose the
    process of the price validation test, including the methodology and process that Maxim will use to select price bands for purposes
    of applying the price validation test.

Response: The Company has disclosed in
Amendment No. 1 the process of the price validation test, including the methodology and process that Maxim will use to select price bands
for purposes of applying the price validation test, as requested. Please see the additional disclosure on page 77.

    3.
    We note that Maxim Group
    will serve as the company’s financial advisor in connection with the direct offering on Nasdaq. Please tell us whether Maxim
    is considered independent under Nasdaq’s listing standards for direct listings. Please tell us whether Maxim provided any investing
    banking services to the company within the 12 months preceding the valuation or has engaged in investment banking services to the
    company in connection with the proposed listing, any related financings or other related transactions.

Response: The Company acknowledges the
Staff’s comment and respectfully advises that Maxim is considered independent under Nasdaq’s listing standards for direct
listings. Neither Maxim nor any affiliated entity has provided any investment banking services to the Company within the past 12 months or has engaged in investment banking services to the Company in connection with the proposed listing, any related
financings or other related transactions.

Signatures, page II-6

    4.
    We note that Nadir Ali
    has signed the registration statement on behalf of the registrant. Please revise the Signatures section to also include Mr. Ali's
    signature in his capacity as the registrant’s chief executive officer and director. Refer to the Instructions to Signatures
    in Form S-1.

Response: The Company acknowledges the
Staff’s comment and has revised the Signatures section to also include Mr. Ali’s signature in his capacity as the registrant’s
chief executive officer and director. Please see the revised Signatures section on page II-6.

*     *     *

We hope that the foregoing has been helpful to
the Staff’s understanding of the Company’s disclosure and that the disclosure modifications in Amendment No. 1 are satisfactory
to the Staff. If you have any questions or comments about this letter or need any further information, please call the undersigned at
(312) 964-7763.

    Very Truly
    Yours

    By:
    /s/
    Kevin Friedmann

    Kevin Friedmann

    cc:
    Nadir Ali (Grafiti Holding
    Inc.)

    Melanie Figueroa (Grafiti
    Holding Inc.)

    Siyuan An (Norton Rose
    Fulbright US LLP)